NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1528025319 MD
Verify on CMS → Mark Lupo, MD
Endocrinology, Diabetes & Metabolism Physician in Sarasota, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 360 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
27%
generic claims · 73% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.8/100
▲ 6 pts above national avg 83.5 · Exceptional
Industry payments
$64.9K
53 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mark Lupo, MD reported a CMS MIPS final score of 89.8/100 - above the 83.5 national average - and filed 1,245 Medicare Part D claims in 2023.
- 89.8/100
- MIPS score · +6 vs avg
- 1K
- Part D claims, 2023
- 27%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Mark Lupo, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1528025319), first enumerated 04/27/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,245 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 89.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$64.9K in reported industry payments (53 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Florida statewide board action statistics are published annually — these figures describe aggregate state activity, not Mark Lupo, MD's individual license status. Verify directly with the state medical board.
Source: FLDOH annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1528025319 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1528025319
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-ABOVE 89.8/100
- RX-MID 1,245
- BOOK-LIGHT 519 in Florida
- PHOTO-FINISH Damilola Ashorobi · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Lupo · this prov…
Lupo · this provider
89.8 MIPS pts
- Ahmed Elsherif ·…
Ahmed Elsherif
89.9 MIPS pts
- Damilola Ashorob…
Damilola Ashorobi
89.9 MIPS pts
- Alberto Chavez V…
Alberto Chavez Velazquez
89.9 MIPS pts
- Hilda Draeger · …
Hilda Draeger
89.9 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mark Lupo, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
90 ≥ 56th percentile 56% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Lupo, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Lupo, MD writes more Part D claims than 32% of them and scores higher on MIPS quality than 60% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Mark Lupo, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Lupo, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Lupo, MD?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,245 53% vs specialty avg
MIPS final score
89.8/100 6.3 pts vs avg
Specialty distribution in Florida
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Mark Lupo, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 89.8/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1528025319 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/27/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
89.8396
Final Score
Measured-score avg: 83.5
82.6175
Quality
98
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Mark Lupo, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Mark A. Lupo,m.d.,p.a.
Sarasota, FL
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Lupo, MD. Source: openpaymentsdata.cms.gov.
Total received
$64.9K
Largest payer
Eisai Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Mark Lupo, MD. To verify Mark Lupo, MD's current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Mark Lupo, MD - brand share 73.0%
Endocrinology, Diabetes & Metabolism Physician average
73% brand-name claims vs 27% generic, on 1,245 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,245
Total Claims
$99K
Total Drug Cost
360
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,299
- Total Day Supply
- 98,410
- Brand vs Generic
- 73% brand / 27% generic
- Brand Drug Cost
- $89K
- Generic Drug Cost
- $10K
Patient Demographics
- Average Patient Age
- 76.1 years
- Avg HCC Risk Score
- 1.15
- Gender Split
- 79% female / 21% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Lupo, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Synthroid
Synthroid
527 claims
- Levothyroxine Sodium
Levothyroxine Sodium
407 claims
- Liothyronine Sodium 80
Liothyronine Sodium
80 claims
- Methimazole 64
Methimazole
64 claims
- Levoxyl 44
Levoxyl
44 claims
- Tirosint 33
Tirosint
33 claims
- Cytomel 24
Cytomel
24 claims
- Unithroid 13
Unithroid
13 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 527 |
| Levothyroxine Sodium | 407 |
| Liothyronine Sodium | 80 |
| Methimazole | 64 |
| Levoxyl Levothyroxine Sodium | 44 |
| Tirosint Levothyroxine Sodium | 33 |
| Cytomel Liothyronine Sodium | 24 |
| Unithroid Levothyroxine Sodium | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in FL →
All providers in Florida →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Mark Lupo, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Mark Lupo, MD's 1,245 claims are below the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Lupo, both outside Florida so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (89.8 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Lupo.
One of 519 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Florida, 5 are shown here.
Dr. Ejigayehu Abate
MD
Jacksonville, FL
Dr. Susan Abend
M.D.
Sarasota, FL
Dr. Daisy Acevedo Morales
MD
South Miami, FL
Dr. Brenda Acosta Ashby
MD
Doral, FL
Dr. Adriane Adami
APRN
Panama City, FL
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mark Lupo, MD's specialty? ▼
Mark Lupo, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Sarasota, Florida. Credentials: MD.
How much does Mark Lupo, MD prescribe under Medicare Part D? ▼
In 2023, Mark Lupo, MD wrote 1,245 Medicare Part D claims totaling $99K in drug costs for 360 beneficiaries.
What is Mark Lupo, MD's Medicare quality score? ▼
Mark Lupo, MD has a CMS MIPS Final Score of 89.8/100 (Quality: 82.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Lupo, MD located? ▼
Mark Lupo, MD is located at 3050 BEE RIDGE RD, Sarasota, FL, 34239. Phone: (941) 342-9750.
What is Mark Lupo, MD's NPI number? ▼
Mark Lupo, MD's National Provider Identifier (NPI) is 1528025319, issued on 04/27/2006.
Does Mark Lupo, MD prescribe more brand-name or generic drugs? ▼
Mark Lupo, MD's prescribing is 73% brand-name and 27% generic drugs by claim count, with $89K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Mark Lupo, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Lupo, MD's most frequently prescribed drugs include Synthroid, Levothyroxine Sodium, Liothyronine Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Lupo, MD accept Medicare? ▼
Mark Lupo, MD appears in CMS Medicare data with 1,245 Part D claims and 360 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Lupo, MD's credentials? ▼
Mark Lupo, MD's NPI is 1528025319 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.